These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4054579)

  • 1. A biochemical study of cholinergic-dopaminergic interactions in the central nervous system.
    De Souza H; Palermo-Neto J
    Gen Pharmacol; 1985; 16(5):533-6. PubMed ID: 4054579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of systemically applied cholinergic drugs on the striatal release of dopamine and its metabolites, as determined by automated brain dialysis in conscious rats.
    Damsma G; Westerink BH; de Vries JB; Horn AS
    Neurosci Lett; 1988 Jul; 89(3):349-54. PubMed ID: 2458554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholinergic effect on the dopamine turnover in the rat corpus striatum].
    Oelszner W; Funk KF; Schwarzenfeld IV; Staib AH; Westermann KH
    Acta Biol Med Ger; 1975; 34(4):647-53. PubMed ID: 1189838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased striatal dopamine turnover following acute administration of rotenone to mice.
    Thiffault C; Langston JW; Di Monte DA
    Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
    Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
    Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age influences abnormalities in striatal dopamine metabolism during and after transient forebrain ischemia.
    Ding A; Németh G; Hoyer S
    J Neural Transm Park Dis Dement Sect; 1992; 4(3):213-25. PubMed ID: 1627255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats.
    Chapman CD; Gazzara RA; Howard SG
    Neuropharmacology; 1990 Apr; 29(4):319-25. PubMed ID: 2342635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.
    Radhakishun FS; Korf J; Venema K; Westerink BH
    Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat.
    Koda H; Hashimoto T; Kuriyama K
    Eur J Pharmacol; 1989 Mar; 162(3):501-8. PubMed ID: 2744083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of dopamine release in the denervated striatum.
    Altar CA; Marien MR
    Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
    Wood PL; Nair NP; Bozarth M
    Neurosci Lett; 1982 Oct; 32(3):291-4. PubMed ID: 6294566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN; Sobotka TJ; Weise VK; Markey SP
    J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine turnover during treadmill running in the rat: relation to the speed of running.
    Hattori S; Naoi M; Nishino H
    Brain Res Bull; 1994; 35(1):41-9. PubMed ID: 7953756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of inorganic mercury (HgCl(2)) on striatal dopaminergic system.
    Faro LR; do Nascimento JL; Alfonso M; Durán R
    Ecotoxicol Environ Saf; 2001 Mar; 48(3):263-7. PubMed ID: 11222035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the anti-dementia drug hopantenate calcium upon striatal dopaminergic neurons in young and aged rats.
    Toide K
    Arch Int Pharmacodyn Ther; 1989; 299():7-13. PubMed ID: 2570556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
    Waldmeier PC; Maitre L
    Eur J Pharmacol; 1978 Jan; 47(2):191-200. PubMed ID: 23298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.